David M. Jauch is responsible for Government Relations within Global Regulatory Affairs of Fresenius Kabi. He is the Chairman of the Global Policy and Market Committee, Member of the Board of Medicines for Europe as well as a member of the Trade Committees of IGBA (International Generics and Biosimilar Association). Also, David is a member of the regulatory committee of the German Pharmaceutical Industry Association (BPI). David’s studied Business Administration at the University of Stuttgart in Germany, Tongji University in China and Seoul National University in Korea and holds an Executive Master in Business Management of Leeds University Business School in the UK.